There’s Reason For Concern Over Natera, Inc.’s (NASDAQ:NTRA) Price
Natera, Inc.’s (NASDAQ:NTRA) price-to-sales (or “P/S”) ratio of 11.4x might make it look like a sell right now compared to the Biotechs industry in the United States, where around half of the companies have P/S ratios below 8x and even P/S below 2x are quite common. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s as high as it is.
View our latest analysis for Natera
What Does Natera’s Recent Performance Look Like?
Recent times haven’t been great for Natera as its revenue has been rising slower than…
